F. Lauriero et al., I-131 MIBG SCINTIGRAPHY OF NEUROECTODERMAL TUMORS - COMPARISON BETWEEN I-131 MIBG AND IN-111 DTPA-OCTREOTIDE, Clinical nuclear medicine, 20(3), 1995, pp. 243-249
An account is given of the results observed with I-131 MIBG scintigrap
hy in four patients (1 bladder pheochromocytoma, 3 neuroblastomas) cho
sen on account of their particular clinical and diagnostic interest fr
om a series of 41 apudoma patients examined by means of this technique
. In the first patient, the unusual site of the tumor in the posterior
wall of the bladder meant that its detection by I-131 MIBG was only p
ossible after catheterization of the bladder. In the second patient, u
ptake in the metastasis was only evident after removal of the primary
tumor. In the third patient, the scintiscan revealed several metastase
s (some in bone) not detected by CT. In the fourth patient (congenital
neuroblastoma), enhanced uptake accompanied the appearance of high pl
asma catecholamine and urinary vanillylhandelic acid values, suggestin
g a functional switch from a nonsecreting to a secreting form. A suppl
ementary In-111 DTPA-Octreotide (OCT) scintiscan of this patient demon
strated the presence of somatostatin receptors on the neuroblasts. Thu
s, this examination would seem particularly useful for the differentia
tion of nonsecreting neuroblastomas. Its employment in assessment of t
he therapeutic capacity of OCT itself is also suggested.